Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    MS-LAQ-301
Show Display Options
Rank Status Study
1 Active, not recruiting A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course
Condition: Relapsing Multiple Sclerosis (RMS)
Intervention: Drug: Laquinimod
2 Completed Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis
Interventions: Drug: Laquinimod;   Other: Placebo

Indicates status has not been verified in more than two years